These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7949151)

  • 1. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease.
    Tanner JE; Menezes J
    Blood; 1994 Dec; 84(11):3956-64. PubMed ID: 7949151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE; Alfieri C
    Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.
    Bilger A; Plowshay J; Ma S; Nawandar D; Barlow EA; Romero-Masters JC; Bristol JA; Li Z; Tsai MH; Delecluse HJ; Kenney SC
    Oncotarget; 2017 Jul; 8(27):44266-44280. PubMed ID: 28574826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E inhibits cyclosporin A and H2O2 promoted Epstein-Barr virus (EBV) transformation of human B cells as assayed by EBV oncogene LMP1 expression.
    Chen C; Reddy KS; Johnston TD; Khan TT; Ranjan D
    J Surg Res; 2003 Aug; 113(2):228-33. PubMed ID: 12957134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents.
    Barkholt LM; Dahl H; Enbom M; Lindé A
    Transpl Int; 1996; 9(5):439-45. PubMed ID: 8875785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.
    Beatty PR; Krams SM; Esquivel CO; Martinez OM
    Transplantation; 1998 May; 65(9):1248-55. PubMed ID: 9603175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-NK cells interactions and lymphoproliferative disorders.
    Kanegane H; Yachie A; Miyawaki T; Tosato G
    Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse.
    Gan R; Yin Z; Liu T; Wang L; Tang Y; Song Y
    Cancer Sci; 2003 Sep; 94(9):796-801. PubMed ID: 12967478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus.
    Ranjan D; Siquijor A; Johnston TD; Wu G; Nagabhuskahn M
    Am Surg; 1998 Jan; 64(1):47-51; discussion 51-2. PubMed ID: 9457037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
    D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
    J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220.
    Tanner JE; Alfieri C; Chatila TA; Diaz-Mitoma F
    J Virol; 1996 Jan; 70(1):570-5. PubMed ID: 8523572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A up-regulates and activates protein kinase C-zeta in EBV-infected and EBV-transformed human B-cells.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    J Surg Res; 2009 May; 153(1):156-61. PubMed ID: 18486150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ; Perrine SP; Faller DV
    Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
    McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
    Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.